Navigation Links
UPDATE: Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
Date:3/8/2013

WARSAW, Ind., March 8, 2013 /PRNewswire/ -- This press release is being issued to revise Zimmer's previous press release regarding the record date for the Company's first quarter 2013 dividend.  Previously, the record date was stated as March 29, 2013.  The correct record date is March 28, 2013.

Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that its Board of Directors has approved the payment of an increased quarterly cash dividend to stockholders for the first quarter of 2013.  The new payment represents an increase of 11% over the dividend paid for the first quarter of 2012. 

"Zimmer is committed to returning considerable value to our stockholders through sales growth, operational excellence and disciplined capital allocation.  We are pleased that successful execution of our operational excellence agenda, coupled with our rigorous financial and operational discipline, has provided us with an opportunity to increase our dividend payment to stockholders for the first quarter of 2013," said David Dvorak, Zimmer President and CEO.  "The increase in our dividend also reflects our ongoing confidence in the Company's future and our capacity to generate cash and create value for our stockholders.  Throughout 2013, an extensive array of new product launches in our core reconstructive product categories and in new, adjacent categories will strengthen Zimmer's established leadership in musculoskeletal healthcare."

The increased quarterly cash dividend of $0.20 per share will be paid on April 26, 2013, to stockholders of record as of the close of business on March 28, 2013.  Future declarations of dividends are subject to approval of the Board of Directors and may be adjusted as business needs or market conditions change.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2012 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 8,500 employees worldwide.

Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lance Armstrong Update: Arrogant Even After Conceding Doping Charges, Asserts Former White House & WADA Spokesman Robert Weiner; Victory for Clean Sport but "Dark Message" Is Science Must Catch Up to Masking Agents Allowing Cheating
2. Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
3. Zimmer Holdings to Present at Canaccord Genuitys Musculoskeletal Conference
4. Zimmer Holdings to Present at Barclays Capital 2013 Global Healthcare Conference
5. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
6. Zimmer Reports Fourth Quarter and 2012 Financial Results
7. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
8. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
9. Zimmer Holdings to Present at 24th Annual Piper Jaffray Healthcare Conference
10. Zimmer Launches Smartphone Comeback App Globally
11. Zimmer Holdings to Present at Credit Suisse 2012 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):